EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico drug repurposing at the cytoplasmic surface of human aquaporin 1

Aled R Lloyd iD, Karl Austin-Muttitt, Jonathan G L Mullins

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Aled R Lloyd und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genome and Structural Bioinformatics Group, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, United Kingdom. Hauptthemen laut MEDLINE: Aquaporin 1, Drug Repositioning, Molecular Docking Simulation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aquaporin 1 (AQP1) is a key channel for water transport in peritoneal dialysis. Inhibition of AQP1 could therefore impair water transport during peritoneal dialysis. It is not known whether inhibition of AQP1 occurs unintentionally due to off-target interactions of administered medications. A high-throughput virtual screening study has been performed to investigate the possible binding of licensed medications to the water pore of human AQP1. A complete model of human AQP1 based on its canonical sequence was assembled using I-TASSER and MODELLER. The model was refined via the incorporation of pore water molecules from a high-resolution yeast aquaporin structure. Docking studies were conducted for the cytoplasmic domain of the AQP1 monomer against a library of all compounds listed in the British National Formulary (BNF), using the PLANTS software with the ChemPLP scoring function. The stability of the best docked conformations within the intrinsic water pore was assessed via short 15 nanosecond molecular dynamics (MD) simulations using the GROMACS-on-Colab utility. Of the 1512 compounds tested, 1002 docking results were obtained, and 198 of these conformations occupied a position within the intrinsic water pore. 30 compounds with promising docking scores were assessed by MD. The docked conformations for dopamine, gabapentin, pregabalin, and methyldopa were stable in these short MD studies. For furosemide and pravastatin, the MD trajectory suggested a binding mode different to the docking result. A small set of compounds which could impede water transport through human AQP1 have been identified in this computational screening study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aquaporin 1Drug RepositioningMolecular Docking SimulationMolecular Dynamics SimulationHumansCytoplasmWaterProtein BindingComputer Simulation

Substanzen

Aquaporin 1AQP1 protein, humanWater

Autor:innen und Institutionen

  • Genome and Structural Bioinformatics Group, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, United Kingdom.

ORCID-Profile: Aled R Lloyd

Zitieren

APA

Lloyd, A. R., Austin-Muttitt, K., & Mullins, J. G. L. (2025). In silico drug repurposing at the cytoplasmic surface of human aquaporin 1. PLOS ONE. https://doi.org/10.1371/journal.pone.0314151

Vancouver

Lloyd AR, Austin-Muttitt K, Mullins JGL. In silico drug repurposing at the cytoplasmic surface of human aquaporin 1. PLOS ONE. 2025. doi:10.1371/journal.pone.0314151

BibTeX
@article{Lloyd2025,
  author = {Lloyd, Aled R and Austin-Muttitt, Karl and Mullins, Jonathan G L},
  title = {In silico drug repurposing at the cytoplasmic surface of human aquaporin 1},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0314151}
}
Kostenlos starten →